Finch Therapeutics Group, Inc. — All Filings
173 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
144
15-12G
25
3
4
4/A
424B4
8-A12B
8-K
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
POS AM
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-8
S-8 POS
SC 13D
SC 13G
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| DEF 14A | DEF 14A | 0000950170-23-014774 | Apr 26, 2023 | Jun 8, 2023 |
| 8-K | 8-K | 0000950170-23-014424 | Apr 25, 2023 | Apr 21, 2023 |
| 8-K | 8-K | 0000950170-23-013276 | Apr 18, 2023 | Apr 12, 2023 |
| PRE 14A | PRE 14A | 0000950170-23-012881 | Apr 14, 2023 | Jun 8, 2023 |
| S-8 | S-8 | 0001193125-23-077910 | Mar 23, 2023 | — |
| 10-K | 10-K | 0000950170-23-009490 | Mar 23, 2023 | Dec 31, 2022 |
| 8-K | 8-K | 0000950170-23-009487 | Mar 23, 2023 | — |
| 4 | FORM 4 SUBMISSION | 0000899243-23-005985 | Feb 23, 2023 | Feb 21, 2023 |
| 8-K | 8-K | 0000950170-23-001236 | Jan 26, 2023 | Jan 25, 2023 |
| 8-K | 8-K | 0000950170-23-001046 | Jan 24, 2023 | Jan 23, 2023 |
| 8-K | 8-K | 0000950170-23-000285 | Jan 6, 2023 | — |
| 8-K | 8-K | 0000950170-22-026337 | Dec 12, 2022 | — |
| 8-K | 8-K | 0000950170-22-024697 | Nov 14, 2022 | — |
| 10-Q | 10-Q | 0000950170-22-024152 | Nov 10, 2022 | Sep 30, 2022 |
| 8-K | 8-K | 0000950170-22-024143 | Nov 10, 2022 | — |
| 4 | FORM 4 SUBMISSION | 0000899243-22-034125 | Oct 25, 2022 | Oct 21, 2022 |
| 4 | FORM 4 SUBMISSION | 0000899243-22-034122 | Oct 25, 2022 | Oct 21, 2022 |
| 8-K | 8-K | 0000950170-22-018005 | Sep 1, 2022 | — |
| 8-K | 8-K | 0000950170-22-017792 | Aug 25, 2022 | Aug 19, 2022 |
| 10-Q | 10-Q | 0000950170-22-016637 | Aug 11, 2022 | Jun 30, 2022 |
| 8-K | 8-K | 0000950170-22-016635 | Aug 11, 2022 | — |
| 8-K | 8-K | 0000950170-22-011723 | Jun 16, 2022 | Jun 10, 2022 |
| 4 | OWNERSHIP DOCUMENT | 0000950142-22-001934 | Jun 15, 2022 | Jun 13, 2022 |
| 4 | FORM 4 SUBMISSION | 0000899243-22-022624 | Jun 15, 2022 | Jun 13, 2022 |
| 4 | FORM 4 SUBMISSION | 0000899243-22-022623 | Jun 15, 2022 | Jun 13, 2022 |
| 4 | FORM 4 SUBMISSION | 0000899243-22-022622 | Jun 15, 2022 | Jun 13, 2022 |
| 4 | FORM 4 SUBMISSION | 0000899243-22-022621 | Jun 15, 2022 | Jun 13, 2022 |
| 4 | FORM 4 SUBMISSION | 0000899243-22-022620 | Jun 15, 2022 | Jun 13, 2022 |
| 4 | FORM 4 SUBMISSION | 0000899243-22-022619 | Jun 15, 2022 | Jun 13, 2022 |
| 4 | FORM 4 SUBMISSION | 0000899243-22-022614 | Jun 15, 2022 | Jun 13, 2022 |
| 4 | FORM 4 SUBMISSION | 0000899243-22-022612 | Jun 15, 2022 | Jun 13, 2022 |
| 4 | FORM 4 SUBMISSION | 0000899243-22-022611 | Jun 15, 2022 | Jun 13, 2022 |
| EFFECT | — | 9999999995-22-001677 | Jun 2, 2022 | — |
| CORRESP | — | 0001193125-22-164092 | May 31, 2022 | — |
| UPLOAD | — | 0000000000-22-005803 | May 26, 2022 | — |
| S-3 | S-3 | 0001193125-22-158515 | May 24, 2022 | — |
| 10-Q | 10-Q | 0000950170-22-009936 | May 16, 2022 | Mar 31, 2022 |
| 8-K | 8-K | 0000950170-22-009935 | May 16, 2022 | — |
| 8-K | 8-K | 0000950170-22-006581 | Apr 28, 2022 | — |
| DEFA14A | DEFA14A | 0000950170-22-006238 | Apr 26, 2022 | — |
| DEF 14A | DEF 14A | 0000950170-22-006234 | Apr 26, 2022 | Jun 10, 2022 |
| 8-K | 8-K | 0000950170-22-005787 | Apr 19, 2022 | Apr 14, 2022 |
| S-8 | S-8 | 0001193125-22-092112 | Mar 31, 2022 | — |
| 10-K | 10-K | 0000950170-22-005243 | Mar 31, 2022 | Dec 31, 2021 |
| 8-K | 8-K | 0000950170-22-005242 | Mar 31, 2022 | — |
| 8-K | 8-K | 0001193125-22-061539 | Mar 1, 2022 | Feb 24, 2022 |
| 4 | FORM 4 SUBMISSION | 0001209191-22-013774 | Feb 28, 2022 | Feb 25, 2022 |
| 4 | FORM 4 SUBMISSION | 0001209191-22-013770 | Feb 28, 2022 | Feb 25, 2022 |
| 4 | FORM 4 SUBMISSION | 0001209191-22-013767 | Feb 28, 2022 | Feb 25, 2022 |
| SC 13G | SCHEDULE 13G, AMENDMENT 1 | 0001014108-22-000050 | Feb 14, 2022 | — |